Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. The lancet. Gastroenterology & hepatology Tseng, C. H., Hsu, Y. C., Nguyen, M. H. 2021; 6 (2): 87–88

View details for DOI 10.1016/S2468-1253(20)30395-2

View details for PubMedID 33444533